CancerLinQ Overview
- Year Founded
-
2014
- Status
-
Acquired/Merged
- Employees
-
462
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
1
CancerLinQ General Information
Description
Developer of a healthcare software platform intended to support oncology practices and researchers in the United States. The company provides a system that collects and analyzes oncology patient data from electronic health records and offers data dashboards, quality reporting tools and research datasets to help clinicians evaluate treatment patterns and improve cancer care delivery.
Contact Information
Website
www.cancerlinq.org(Operating Subsidiary)
Corporate Office
- 1120 Anenue
- Cambridge, MA
- United States
Corporate Office
- 1120 Anenue
- Cambridge, MA
- United States
CancerLinQ Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
CancerLinQ Comparisons
Industry
Financing
Details
CancerLinQ Competitors (49)
One of CancerLinQ’s 49 competitors is Aetion, a Private Equity-Backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Aetion | Private Equity-Backed | New York, NY | ||||
| OncoLens | Venture Capital-Backed | Atlanta, GA | ||||
| Ibex Medical Analytics | Venture Capital-Backed | Tel Aviv, Israel | ||||
| Translational Software | Corporation | Bellevue, WA | ||||
| NantHealth | Formerly VC-backed | Lewisville, TX |
CancerLinQ Signals
CancerLinQ Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
CancerLinQ FAQs
-
When was CancerLinQ founded?
CancerLinQ was founded in 2014.
-
Where is CancerLinQ headquartered?
CancerLinQ is headquartered in Cambridge, MA.
-
What is the size of CancerLinQ?
CancerLinQ has 462 total employees.
-
What industry is CancerLinQ in?
CancerLinQ’s primary industry is Decision/Risk Analysis.
-
Is CancerLinQ a private or public company?
CancerLinQ is a Private company.
-
What is CancerLinQ’s current revenue?
The current revenue for CancerLinQ is .
-
Who are CancerLinQ’s investors?
American Society of Clinical Oncology has invested in CancerLinQ.
-
Who are CancerLinQ’s competitors?
Aetion, OncoLens, Ibex Medical Analytics, Translational Software, and NantHealth are some of the 49 competitors of CancerLinQ.
-
When was CancerLinQ acquired?
CancerLinQ was acquired on 11-Dec-2023.
-
Who acquired CancerLinQ?
CancerLinQ was acquired by ConcertAI.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process